Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Gene expression profiling of gastric mucosa in mice lacking CCK and gastrin receptors

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Natriuretic peptides and cerebral hemodynamics

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Adropin: a new regulatory peptide in cardiovascular endocrinology

    Research output: Contribution to journalJournal articleResearch

  4. Cardiac C-type natriuretic peptide gene expression and plasma concentrations in neonatal piglets

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Gut hormones - Team workers or solo trippers?

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The ileocolonic brake is impaired in short bowel syndrome (SBS) patients with distal bowel resections. An attenuated meal-stimulated hormone secretion may cause gastric hypersecretion, rapid gastric and intestinal transit and a poor adaptation. Attempting to restore this ileocolonic brake, this study evaluated the acute effects of continuous intravenous administration of glucagon-like peptide (GLP) 1 and 2, alone or in combination, on gastrointestinal function in SBS patients.
Original languageEnglish
JournalRegulatory Peptides
Volume184
Pages (from-to)30-9
Number of pages10
ISSN0167-0115
DOIs
Publication statusPublished - 10 Jun 2013

ID: 42487402